Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5551
PUT
Brunswick
BC
$5.16B
| $28K | ﹤0.01% |
500
-5,500
| -92% | -$309K |
|
5552
City Holding Co
CHCO
$2.05B
| $28K | ﹤0.01% |
400
-1,732
| -81% | -$112K |
|
5553
Caesars Entertainment
CZR
$6.06B
| $28K | ﹤0.01% |
1,111
-16,037
| -94% | -$356K |
|
5554
CALL
MKS Inc
MKSI
$20.9B
| $28K | ﹤0.01% |
300
+200
| +200% | +$16.4K |
|
5555
PUT
Northern Trust
NTRS
$33.3B
| $28K | ﹤0.01% |
300
+200
| +200% | +$18.1K |
|
5556
SiriusPoint
SPNT
$2.75B
| $28K | ﹤0.01% |
1,780
-8,078
| -82% | -$116K |
|
5557
PUT
Sunoco
SUN
$14.6B
| $28K | ﹤0.01% |
900
-20,700
| -96% | -$645K |
|
5558
CALL
Supernus Pharmaceuticals
SUPN
$2.67B
| $28K | ﹤0.01% |
700
+500
| +250% | +$21.6K |
|
|
HTLF
5559
DELISTED
Heartland Financial USA, Inc.
HTLF
| $28K | ﹤0.01% |
570
+540
| +1,800% | +$24.7K |
|
|
PRFT
5560
DELISTED
Perficient Inc
PRFT
| $28K | ﹤0.01% |
1,379
-5,944
| -81% | -$108K |
|
|
DBGR
5561
DELISTED
Xtrackers MSCI Germany Hedged Equity ETF
DBGR
| $28K | ﹤0.01% |
1,000
| – | – |
|
|
WBT
5562
CALL
DELISTED
Welbilt, Inc.
WBT
| $28K | ﹤0.01% |
1,200
| – | – |
|
|
NTUS
5563
DELISTED
Natus Medical Inc
NTUS
| $28K | ﹤0.01% |
752
-6,479
| -90% | -$229K |
|
|
LOGM
5564
CALL
DELISTED
LogMein, Inc.
LOGM
| $28K | ﹤0.01% |
255
| – | – |
|
|
BGG
5565
CALL
DELISTED
Briggs & Stratton Corp.
BGG
| $28K | ﹤0.01% |
1,200
-600
| -33% | -$13.6K |
|
|
NTRI
5566
CALL
DELISTED
NutriSystem, Inc.
NTRI
| $28K | ﹤0.01% |
500
-7,700
| -94% | -$417K |
|
|
GCI
5567
CALL
DELISTED
Gannett Co., Inc
GCI
| $28K | ﹤0.01% |
3,100
+1,900
| +158% | +$16.3K |
|
5568
Alamos Gold
AGI
$12B
| $27K | ﹤0.01% |
4,030
+2,195
| +120% | +$16.2K |
|
5569
PUT
American Superconductor
AMSC
$1.5B
| $27K | ﹤0.01% |
6,000
+5,500
| +1,100% | +$21.3K |
|
5570
PUT
ArcBest
ARCB
$3.07B
| $27K | ﹤0.01% |
800
-100
| -11% | -$2.63K |
|
5571
Assembly Biosciences
ASMB
$503M
| $27K | ﹤0.01% |
64
+63
| +6,300% | +$19.3K |
|
|
BRKL
5572
DELISTED
Brookline Bancorp
BRKL
| $27K | ﹤0.01% |
1,742
-7,351
| -81% | -$107K |
|
5573
Camden National
CAC
$1B
| $27K | ﹤0.01% |
621
+213
| +52% | +$8.71K |
|
5574
Kadant
KAI
$3.83B
| $27K | ﹤0.01% |
276
+177
| +179% | +$15K |
|
5575
CALL
Ligand Pharmaceuticals
LGND
$5.85B
| $27K | ﹤0.01% |
321
| – | – |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.